A mesangium-predominant gene, megsin, is a new serpin upregulated in IgA nephropathy

Journal of Clinical Investigation

Volumn 102, Issue 4, 1998, Pages 828-836

  Miyata, Toshio ^a   Nangaku, Masaomi ^a   Suzuki, Daisuke ^a   Inagi, Reiko ^a   Uragami, Ken Ichi ^a   Sakai, Hideto ^a   Okubo, Kousaku ^b   Kurokawa, Kiyoshi ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

3' directed cDNA library; Cell specific protein; Glomerulonephritis; Mesangial proliferation; Serpin

Indexed keywords

CELL PROTEIN; SERINE PROTEINASE INHIBITOR;

ARTICLE; CELL PROLIFERATION; COMPUTER ANALYSIS; DNA SEQUENCE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN A NEPHROPATHY; MESANGIUM CELL; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY;

EID: 0032528967     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI2450     Document Type: Article

References (38)

1. Yasuda, Y., T. Miyata, M. Nangaku, Y. Iida, K. Maeda, K. Kurokawa, and K. Okuho. 1998. Functional quantitative analysis of the genome in cultured human mesangial cells. Kidney Int. 53:154-158.
2. Striker, G.E., and L.J. Striker. 1985. Glomerular cell culture. Lab. Invest. 53:122-132.
3. Bairoch, A. 1992. PROSITE: a dictionary of sites and patterns in proteins. Nucleic Acids Res. 20:2013-2018.
4. Bairoch, A., P. Bucher, and K. Hofmann. 1996. The PROSITE database: its status in 1995. Nucleic Acids Res. 24:189-196.
5. Ogiwara, A., I. Uchiyama, Y. Seto, and M. Kanehisa. 1992. Construction of a dictionary of sequence motifs that characterize groups of related proteins. Protein Eng. 5:479-488.
6. Pearson, W.R., and D.J. Lipman. 1988. Improved tools for biological sequence comparison. Proc. Natl. Acad. Sci. USA. 85:2444-2448.
7. Kyte, J., and R.F. Doolittle. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:105-132.
8. Rost, B., and C. Sander. 1993. Prediction of protein structure at better than 70% accuracy. J. Mol. Biol. 232:584-599.
9. Suzuki, D., M. Miyazaki, K. Jinde, T. Koji, M. Yagame, M. Endoh, Y. Nomoto, and H. Sakai. 1997. In situ hybridization studies of matrix metalloproteinase-3, tissue inhibitor of metalloproteinase-1 and type IV collagen in diabetic nephropathy. Kidney Int. 52:111-119.
10. Matsubara, K., and K. Okubo. 1993. cDNA analyses in the human genome project. Gene. 135:265-274.
11. Okubo, K., N. Hori, R. Matoba, T. Niiyama, A. Fukushima, Y. Kojima, and K. Matsubara. 1992. Large scale cDNA sequencing for analysis of quantitative and qualitative aspects of gene expression. Nat. Genet. 2:173-179.
12. Carrell, R., and J. Travis. 1985. α1-Antitrypsin and the serpins: variation and countervariation. Trends Biochem. Sci. 10:20-24.
13. Carrell, R., P.A. Pemberton, and D.R. Boswell. 1987. The serpins: evolution and adaptation in a family of protease inhibitors. Cold Spring Harbor Symp. Quant. Biol. 52:527-535.
14. Kruithof, E.K.O., M.S. Baker, and C.L. Bunn. 1995. Biological and clinical aspects of plasminogen activator inhibitor type 2. Blood. 86:4007-4024.
15. Potempa, J., E. Korzus, and J. Travis. 1994. The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J. Biol. Chem. 269: 15957-15960.
16. Remold-O'Donnell, E. 1993. The ovalbumin family of serpin proteins. FEBS Lett. 315:105-108.
17. Aertgeerts, K., H.L. De Bondt, C.J. De Ranter, and P.J. Declerck. 1995. Mechanisms contributing to the conformational and functional flexibility of plasminogen activator inhibitor-1. Nat. Struct. Biol. 2:891-897.
18. Hopkins, P.C., and J. Whisstock. 1994. Function of mapsin. Science. 265: 1893-1894.
19. Patston, P.A., and P.G.W. Gettins. 1996. Significance of secondary structure predictions on the reactive center loop region of serpins: a model for the folding of serpins into a metastable state. FEBS Lett. 383:87-92.
20. Wright, H.T. 1996. The structural puzzle of how serpin serine protease inhibitors work. Bioessays. 18:453-464.
21. Stein, P.E., and R.W. Carrell. 1995. What do dysfunctional serpins tell us about molecular mobility and disease? Struct. Biol. 2:96-113.
22. Gettins, P., P.A. Patston, and M. Schapira. 1993. The role of conformational change in serpin structure and function. Bioessays. 15:461-467.
23. Creighton, T.E., and I.G. Charles. 1987. Sequences of the genes and polypeptide precursors for two bovine protease inhibitors. J. Mol. Biol. 194:11-22.
24. Ye, R.D., T.-C. Wun, and J.E. Sadler. 1988. Mammalian protein secretion without signal peptide removal: biosynthesis of plasminogen activator inhibitor-2 in U-937 cells. J. Biol. Chem. 263:4869-4875.
25. Wohlwend, A., D. Belin, and J.D. Vassalli. 1987. Plasminogen activator-specific inhibitors in mouse macrophages: in vivo and in vitro modulation of their synthesis and secretion. J. Immunol. 139:1278-1284.
26. Wohlwend, A., D. Belin, and J.D. Vassalli. 1987. Plasminogen activator-specific inhibitors produced by human monocytes/macrophages. J. Exp. Med. 165:320-339.
27. Mikus, P., T. Urano, P. Liljestroem, and T. Ny. 1993. Plasminogen-activator inhibitor type 2 (PAI-2) is a spontaneously polymerising SERPIN: biochemical characterization of the recombinant intracellular and extracellular forms. Eur. J. Biochem. 218:1071-1082.
28. Genton, C., E.K.O. Kruithof, and W.D. Schleuning. 1987. Phorbol ester induces the biosynthesis of glycosylated and non-glycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells. J. Cell Biol. 104:705-712.
29. Miyata, T., K. Isobe, R. Inagi, R. Taguchi, I. Takai, Y. Fujita, T. Iwamoto, T. Hasegawa, K. Maeda, K. Yamada, and I. Nakashima. 1989. Rat mesangial cells actively produce phosphatidylinositol-anchored Thy-1. Immunology. 67:531-533.
30. Johnson, R.J., J. Floege, A. Yoshimura, H. Iida, W.G. Couser, and C.E. Alpers. 1992. The activated mesangial cells: a glomerular "myofibroblast?" J. Am. Soc. Nephrol. 2:S190-S197.
31. Floege, J., H.R. Radeke, and R.J. Johnson. 1994. Glomerular cells in vitro versus the glomerulus in vivo. Kidney Int. 45:360-368.
32. Miyata, T., K. Isobe, R. Dawson, M.A. Ritter, R. Inagi, O. Oda, R. Taguchi, H. Ikezawa, I. Inoue, H. Seo, M. Hasegawa, S. Kobayashi, K. Maeda, K. Yamada, and I. Nakashima. 1990. Determination of the molecular nature and cellular localization of Thy-1 in human renal tissue. Immunology. 69:391-395.
33. Bachmann, F. 1995. The enigma PAI-2: Gene expression, evolutionary and functional aspects. Thromb. Haemostasis. 74:172-179.
34. Eitzman, D.T., R.D. McCoy, X. Zheng, W.P. Fay, T. Shen, D. Ginsburg, and R.H. Simon. 1996. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhihitor-1 gene. J. Clin. Invest. 97:232-237.
35. Dickinson, J.L., E.J. Bates, A. Ferrante, and T.M. Antalis. 1995. Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis. J. Biol. Chem. 270:27894-27904.
36. Kumar, S., and C. Baglioni. 1991. Protection from tumor necrosis factor-mediated cytolysis by overexpression of plasminogen activator inhibitor type-2. J. Biol. Chem. 266:20960-20964.
37. Schechter, I., and A. Berger. 1967. On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27:157-162.
38. Schick, C., Y. Kamachi, A.J. Bartuski, S. Cataltepe, N.M. Schechter, P.A. Pemberton, and G.A. Silverman. 1997. Squamous cell carcinoma antigen 2 is a novel serpin that inhibits the chyotrypsin-like proteases cathepsin G and mast cell chymase. J. Biol. Chem. 272:1849-1855.